About: A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) наукова стаття, опублікована у 2019 (uk)
publication date	wds:Q64230769-AA6A0FAE-D6A9-494F-BE29-1221B9EAFF32
publication date	2019-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64230769-27BE7C79-3B26-4623-8E9B-1049E16972DA
language of work or name	English
cites work	wds:Q64230769-08901AD4-25CB-4894-B083-CDE5429C4516 wds:Q64230769-0F4BCB0C-7690-4332-9B47-38C19EE41887 wds:Q64230769-1CC93ED1-4CA1-4DDE-B7FD-34E2B491B428 wds:Q64230769-2A38A226-3B81-4FF4-B851-B04342CC8FA9 wds:Q64230769-37FD2158-E143-43EA-8D17-4A27CFEC907E wds:Q64230769-3A39CE49-CEDB-4B63-ACB6-1E40CF330988 wds:Q64230769-4217868E-5F06-47D3-9BB9-DC09AE452821 wds:Q64230769-626DCC3D-F7AF-44A8-B9BD-1A10AD250BFD wds:Q64230769-71A723C5-DB2D-49CA-AE21-A492F1FC0EAB wds:Q64230769-734DAF30-2645-47EB-A4D1-3840B11752A4 wds:Q64230769-7A5F0F9C-1E0F-4877-B52D-5DE152DB26DA wds:Q64230769-7B50FB21-F611-48AF-9C08-F18F4CAD89EA wds:Q64230769-8DA24545-10E8-4532-8CBD-BF4F7B2640E6 wds:Q64230769-91A66DF1-D383-40A6-BEF3-E050FEBCAA46 wds:Q64230769-9A3B81CC-12F3-42B8-A257-691CAA5AD41A wds:Q64230769-ACD764C6-D646-49AF-BE3C-86989DF814B5 wds:Q64230769-C4F8EEC9-E22E-4B2F-876A-352DF4C6606C wds:Q64230769-CCCA4178-7433-4779-B4E4-858CEAD316B2 wds:Q64230769-E3559E3C-A9AF-4187-A137-3127B687A77C wds:Q64230769-E77CFE69-00FA-4BCF-8916-BAA9B16EB219 wds:Q64230769-F082B63B-C249-4662-A5D3-33A046D4C7C9 wds:Q64230769-FE33C16D-7337-4D6E-87CF-0888E1B83BB7 wds:Q64230769-FF487519-BB61-4EA3-AA03-26A785E977CC
cites work	Ductal budding and branching patterns in the developing prostate. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group Cancer statistics, 2016 hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer Zinc in the human prostate gland: normal, hyperplastic and cancerous Testosterone and prolactin regulation of metabolic genes and citrate metabolism of prostate epithelial cells Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients Citrate in the diagnosis of prostate cancer Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas. Percutaneous Absorption of Iodochlorhydroxyquin in Humans Evidence that Human Prostate Cancer is a ZIP1-Deficient Malignancy that could be Effectively Treated with a Zinc Ionophore (Clioquinol) Approach Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience Effect of prolactin on the prostate Absorption of 8-hydroxyquinolines through the human skin
author name string	wds:Q64230769-935228DA-27B2-43BD-91C5-A7302B47FA04 wds:Q64230769-DAE8032E-AD71-495E-B6D7-B942EBBE628B
author name string	Renty B Franklin Leslie C Costello
rdfs:label	A Proposed Efficacious Treatment with Clioquinol (nl) A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How? (en)
skos:prefLabel	A Proposed Efficacious Treatment with Clioquinol (nl) A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How? (en)
name	A Proposed Efficacious Treatment with Clioquinol (nl) A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How? (en)
title	wds:Q64230769-E66A4C05-8102-44BF-A448-FE0A51D05106
title	A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal Androgen-independent Prostate Cancer. Why and How? (en)
instance of	wds:Q64230769-D9F278AF-8707-4668-A91F-38994DBCE115
instance of	scholarly article
PubMed ID	wds:Q64230769-FC30B163-02F9-4732-9229-BB0903E1387A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30828702
PubMed ID	30828702
issue	wds:Q64230769-6FB5AE95-6424-4FB4-A96C-F8E22FB64C55
volume	wds:Q64230769-12149F51-5FED-4C6B-BF71-EE4244C174B8
issue	1
volume	2
PMCID	wds:Q64230769-94BAC9EE-A538-46DB-9DFF-E27237F6B4D2
PMCID	6392423
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64230769
is cites work of	A Novel Patient Case Report to Show the Successful Termination of Untreatable Androgen-independent Prostate Cancer: Treatment with Cabergoline (Dopamine agonist)
is cites work of	wds:Q92842920-836B0FB9-96CC-45DB-B225-D0223CCE6824

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software